4//SEC Filing
BARBARI SHARON SURREY 4
Accession 0001209191-20-018220
CIK 0001566044other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:54 PM ET
Size
6.5 KB
Accession
0001209191-20-018220
Insider Transaction Report
Form 4
BARBARI SHARON SURREY
Director
Transactions
- Award
Stock Options
2020-03-09+29,271→ 29,271 totalExercise: $4.50Exp: 2029-05-16→ Common Stock (29,271 underlying)
Footnotes (2)
- [F1]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020.
- [F2]Received in or in connection with the merger of Foamix Pharmaceuticals Ltd. ("Foamix"), and Giants Merger Subsidiary Ltd., a direct, wholly owned subsidiary of Menlo Therapeutics Inc. ("Menlo"), in exchange for Foamix equity securities, as further described in the Form 4 filed by the Reporting Person on the date hereof in respect of the Reporting Person's interests in Foamix equity securities. The Reporting Person also received certain contingent stock rights which are subject to the terms and conditions of the contingent stock rights agreement, dated as of March 9, 2020, by and between American Stock Transfer & Trust Company, LLC and Menlo, or related contractual interests, either of which may entitle the Reporting Person to certain additional Menlo equity securities or the adjustment of certain Menlo equity securities, all as further described in that Current Report on Form 8-K filed by Menlo with the Securities and Exchange Commission on March 9, 2020.
Documents
Issuer
Menlo Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001240499
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:54 PM ET
- Size
- 6.5 KB